Eric M. Schott

1.0k total citations
24 papers, 724 citations indexed

About

Eric M. Schott is a scholar working on Molecular Biology, Rheumatology and Physiology. According to data from OpenAlex, Eric M. Schott has authored 24 papers receiving a total of 724 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Rheumatology and 5 papers in Physiology. Recurrent topics in Eric M. Schott's work include Osteoarthritis Treatment and Mechanisms (8 papers), Gut microbiota and health (7 papers) and Diet and metabolism studies (5 papers). Eric M. Schott is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (8 papers), Gut microbiota and health (7 papers) and Diet and metabolism studies (5 papers). Eric M. Schott collaborates with scholars based in United States, Australia and Germany. Eric M. Schott's co-authors include Michael J. Zuscik, Robert A. Mooney, Steven R. Gill, Christopher W Farnsworth, John Ketz, David A. Villani, Stephen L. Kates, Fadia Kamal, Robert Maynard and Maria J. Soto-Girón and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Scientific Reports.

In The Last Decade

Eric M. Schott

22 papers receiving 704 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric M. Schott United States 11 343 255 156 107 95 24 724
Cindy G. Boer Netherlands 14 331 1.0× 270 1.1× 131 0.8× 102 1.0× 82 0.9× 40 745
Naiomy D. Rios‐Arce United States 13 534 1.6× 115 0.5× 148 0.9× 91 0.9× 40 0.4× 16 795
Ji Ye Kwon South Korea 15 405 1.2× 287 1.1× 77 0.5× 73 0.7× 104 1.1× 21 812
Hamid Y. Dar India 12 622 1.8× 90 0.4× 125 0.8× 59 0.6× 52 0.5× 16 926
Yubiao Zhang China 18 361 1.1× 189 0.7× 67 0.4× 38 0.4× 58 0.6× 39 837
Ramón Pérez‐Cano Spain 17 216 0.6× 94 0.4× 114 0.7× 130 1.2× 37 0.4× 37 780
Necmettın Akdeniz Türkiye 16 171 0.5× 132 0.5× 53 0.3× 66 0.6× 53 0.6× 109 923
Akiko Yagami Japan 21 128 0.4× 239 0.9× 150 1.0× 177 1.7× 87 0.9× 88 1.2k
Morgana Rodrigues Guimarães Brazil 17 286 0.8× 85 0.3× 59 0.4× 51 0.5× 100 1.1× 37 1.0k
Yumi Matsuda Japan 9 307 0.9× 58 0.2× 160 1.0× 43 0.4× 29 0.3× 15 714

Countries citing papers authored by Eric M. Schott

Since Specialization
Citations

This map shows the geographic impact of Eric M. Schott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric M. Schott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric M. Schott more than expected).

Fields of papers citing papers by Eric M. Schott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric M. Schott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric M. Schott. The network helps show where Eric M. Schott may publish in the future.

Co-authorship network of co-authors of Eric M. Schott

This figure shows the co-authorship network connecting the top 25 collaborators of Eric M. Schott. A scholar is included among the top collaborators of Eric M. Schott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric M. Schott. Eric M. Schott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Murphy, Vincent A., Alicia E. Ballok, Maria J. Soto-Girón, et al.. (2024). Food safety assessment and 28-day toxicity study of the synbiotic medical food consortium SBD121. Food and Chemical Toxicology. 191. 114839–114839. 2 indexed citations
4.
Gustafsson, Karin L., Jianyao Wu, Karin Nilsson, et al.. (2022). Development of a synbiotic that protects against ovariectomy-induced trabecular bone loss. American Journal of Physiology-Endocrinology and Metabolism. 322(4). E344–E354. 13 indexed citations
5.
Murphy, Vincent A., Alicia E. Ballok, Maria J. Soto-Girón, et al.. (2022). Food safety assessment and toxicity study of the synbiotic consortium SBD111. Food and Chemical Toxicology. 168. 113329–113329. 3 indexed citations
7.
Soto-Girón, Maria J., et al.. (2021). The Edible Plant Microbiome represents a diverse genetic reservoir with functional potential in the human host. Scientific Reports. 11(1). 24017–24017. 30 indexed citations
8.
Palacios, Talia, Luis Vitetta, Samantha Coulson, et al.. (2020). Targeting the Intestinal Microbiota to Prevent Type 2 Diabetes and Enhance the Effect of Metformin on Glycaemia: A Randomised Controlled Pilot Study. Nutrients. 12(7). 2041–2041. 95 indexed citations
9.
Schott, Eric M., et al.. (2019). Detection of the steroid receptor interacting protein, PAK6, in a neuronal cell line. Heliyon. 5(3). e01294–e01294. 2 indexed citations
10.
Schott, Eric M., David A. Villani, Alex Grier, et al.. (2018). Oral hydrolyzed type 2 collagen protects against the OA of obesity and mitigates obese gut microbiome dysbiosis. Osteoarthritis and Cartilage. 26. S173–S174. 5 indexed citations
11.
Schott, Eric M., Jacquelyn Lillis, Christopher W Farnsworth, et al.. (2018). Early synovial B-cell infiltration as a candidate mechanism of pathogenesis in the OA of obesity. Osteoarthritis and Cartilage. 26. S14–S14. 1 indexed citations
12.
Schott, Eric M., Christopher W Farnsworth, Alex Grier, et al.. (2018). Targeting the gut microbiome to treat the osteoarthritis of obesity. JCI Insight. 3(8). 203 indexed citations
13.
Schott, Eric M., Christopher W Farnsworth, Alex Grier, et al.. (2017). Prebiotic manipulation of the gut microbiome with oligofructose confers protection against the osteoarthritis of obesity. Osteoarthritis and Cartilage. 25. S11–S12. 1 indexed citations
14.
Kamal, Fadia, et al.. (2017). Chondrocyte PTH1R anti-hypertrophic signaling is essential for articular cartilage maintenance and protection post trauma. Osteoarthritis and Cartilage. 25. S13–S14. 1 indexed citations
15.
Schott, Eric M., Robert Maynard, Zhaoyang Liu, et al.. (2017). Daily oral consumption of hydrolyzed type 1 collagen is chondroprotective and anti-inflammatory in murine posttraumatic osteoarthritis. PLoS ONE. 12(4). e0174705–e0174705. 43 indexed citations
16.
Farnsworth, Christopher W, Eric M. Schott, Stephen L. Kates, et al.. (2017). Obesity/type 2 diabetes increases inflammation, periosteal reactive bone formation, and osteolysis during Staphylococcus aureus implant‐associated bone infection. Journal of Orthopaedic Research®. 36(6). 1614–1623. 32 indexed citations
17.
Farnsworth, Christopher W, Eric M. Schott, Majed A. Refaai, et al.. (2017). Adaptive Upregulation of Clumping Factor A (ClfA) by Staphylococcus aureus in the Obese, Type 2 Diabetic Host Mediates Increased Virulence. Infection and Immunity. 85(6). 37 indexed citations
18.
Maynard, Robert, Eric M. Schott, Robert A. Mooney, et al.. (2016). Oral hydrolyzed type 1 collagen induces chondroregeneration and inhibits synovial inflammation in murine posttraumatic osteoarthritis. Osteoarthritis and Cartilage. 24. S532–S533. 3 indexed citations
19.
Müller, Thomas, Alexandre Pico, Eric M. Schott, et al.. (2011). 1304 TH2 CYTOKINE-MEDIATED BILIARY EPITHELIAL CELL (BEC) BARRIER DYSFUNCTION MAY CONTRIBUTE TO IMMUNOGLOBULIN G4 (IGG4) ASSOCIATED SCLEROSING CHOLANGITIS (IAC). Journal of Hepatology. 54. S514–S514. 1 indexed citations
20.
Wong, Johnson T., et al.. (1990). IMMUNOGENIC EPITOPES OF THE p55 CHAIN OF THE IL-2 RECEPTOR RELATIONSHIPS TO HIGH-AFFINITY IL-2 BINDING AND MODULATION OF THE P55 CHAIN. Transplantation. 49(3). 587–595. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026